Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Integrative approach of omics and imaging data to discover new insights for understanding brain diseasesopen access

Authors
Yoon, Jong HyukLee, HagyeongKwon, DayoungLee, DonghaLee, SeulahCho, EunjiKim, JaehoonKim, Dayea
Issue Date
Aug-2024
Publisher
Oxford University Press
Citation
Brain Communications
Journal Title
Brain Communications
URI
http://scholarworks.bwise.kr/kbri/handle/2023.sw.kbri/1189
DOI
10.1093/braincomms/fcae265
ISSN
2632-1297
Abstract
<jats:title>Abstract</jats:title> <jats:p>Treatments that can completely resolve brain diseases have yet to be discovered. Omics is a novel technology that allows researchers to understand the molecular pathways underlying brain diseases. Multiple omics, including genomics, transcriptomics, and proteomics, and brain imaging technologies, such as magnetic resonance imaging, positron emission tomography, and electroencephalography, have contributed to brain disease-related therapeutic target detection. However, new treatment discovery remains challenging. We focused on establishing brain multi-molecular maps using an integrative approach of omics and imaging to provide insights into brain disease diagnosis and treatment. This approach requires precise data collection using omics and imaging technologies, data processing, and normalisation. Incorporating a brain molecular map with the advanced technologies through artificial intelligence will help establish a system for brain disease diagnosis and treatment through regulation at the molecular level.</jats:p>
Files in This Item
There are no files associated with this item.
Appears in
Collections
연구본부 > 퇴행성 뇌질환 연구그룹 > 1. Journal Articles
연구본부 > 인지과학 연구그룹 > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Yoon, Jong Hyuk photo

Yoon, Jong Hyuk
연구본부 (퇴행성 뇌질환 연구그룹)
Read more

Altmetrics

Total Views & Downloads

BROWSE